North America Artificial Intelligence (AI) in Medical Diagnostics Market By Application (Imaging Diagnostics, Genomic Diagnostics, Laboratory Diagnostics, Preventive Diagnostics, and Clinical Decision Support), By Disease (Oncology, Cardiovascular Diseases, Neurological Disorders, Respiratory Diseases, Diabetes, Infectious Diseases, Others), Market Size, Segmental analysis, Country Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. North America Artificial Intelligence (AI) in Medical Diagnostics Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. U.S. healthcare modernization encourages AI adoption for diagnostics improvement.

3.2.2. High healthcare expenditure supports investment in advanced AI diagnostics.

3.2.3. Advanced healthcare infrastructure in North America enables smooth AI integration.

3.3. Key industry pitfalls & challenges

3.3.1. Legal liability concerns impede confidence in AI diagnostic accuracy adoption.

3.3.2. Integration difficulties with outdated systems delay AI diagnostic implementation.

3.3.3. HIPAA regulations limit AI data-sharing and diagnostics implementation growth.

3.4. Market Opportunities

3.4.1. Collaborations with U.S. universities advance AI-driven healthcare diagnostics research.

3.4.2. Venture capital funding drives innovation in North American AI healthcare startups.

3.4.3. AI diagnostics address healthcare gaps in rural North American areas.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. North America Artificial Intelligence (AI) in Medical Diagnostics Market, Application Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Application, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Imaging Diagnostics

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Genomic Diagnostics

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Laboratory Diagnostics

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Preventive Diagnostics

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6. Clinical Decision Support

4.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. North America Artificial Intelligence (AI) in Medical Diagnostics Market, Disease Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Disease, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Oncology

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Cardiovascular Diseases

5.3.1. Market Size and Forecast, By 2025-2035(USD Billion)

5.4. Neurological Disorders

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Respiratory Diseases

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Diabetes

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.7. Infectious Diseases

5.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.8. Others

5.8.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. North America Artificial Intelligence (AI) in Medical Diagnostics Market, Region Segment Analysis

6.1. Overview

6.1.1. Global Market Revenue Share, By Region, 2025 & 2035

6.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

6.2. North America

6.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

6.2.2. North America Market Revenue, By Application, 2025-2035

6.2.3. North America Market Revenue, By Disease, 2025-2035

6.2.4. The U.S.

6.2.4.1. U.S. Market Revenue, By Application, 2025-2035

6.2.4.2. U.S. Market Revenue, By Disease, 2025-2035

6.2.5. Canada

6.2.5.1. Canada Market Revenue, By Application, 2025-2035

6.2.5.2. Canada Market Revenue, By Disease, 2025-2035

7. Company Profile

7.1. Zebra Medical Vision

7.1.1. Business Overview

7.1.2. Financial Performance

7.1.3. Product/Service Offerings

7.1.4. Strategies & recent developments

7.1.5. SWOT Analysis

7.2. Arterys

7.2.1. Business Overview

7.2.2. Financial Performance

7.2.3. Product/Service Offerings

7.2.4. Strategies & recent developments

7.2.5. SWOT Analysis

7.3. Butterfly Network

7.3.1. Business Overview

7.3.2. Financial Performance

7.3.3. Product/Service Offerings

7.3.4. Strategies & recent developments

7.3.5. SWOT Analysis

7.4. Aidoc

7.4.1. Business Overview

7.4.2. Financial Performance

7.4.3. Product/Service Offerings

7.4.4. Strategies & recent developments

7.4.5. SWOT Analysis

7.5. PathAI

7.5.1. Business Overview

7.5.2. Financial Performance

7.5.3. Product/Service Offerings

7.5.4. Strategies & recent developments

7.5.5. SWOT Analysis

7.6. Viz.ai

7.6.1. Business Overview

7.6.2. Financial Performance

7.6.3. Product/Service Offerings

7.6.4. Strategies & recent developments

7.6.5. SWOT Analysis

7.7. Proscia

7.7.1. Business Overview

7.7.2. Financial Performance

7.7.3. Product/Service Offerings

7.7.4. Strategies & recent developments

7.7.5. SWOT Analysis

7.8. Riverain Technologies

7.8.1. Business Overview

7.8.2. Financial Performance

7.8.3. Product/Service Offerings

7.8.4. Strategies & recent developments

7.8.5. SWOT Analysis

7.9. Enlitic

7.9.1. Business Overview

7.9.2. Financial Performance

7.9.3. Product/Service Offerings

7.9.4. Strategies & recent developments

7.9.5. SWOT Analysis

7.10. IBM Watson Health

7.10.1. Business Overview

7.10.2. Financial Performance

7.10.3. Product/Service Offerings

7.10.4. Strategies & recent developments

7.10.5. SWOT Analysis

7.11. Google Health (DeepMind)

7.11.1. Business Overview

7.11.2. Financial Performance

7.11.3. Product/Service Offerings

7.11.4. Strategies & recent developments

7.11.5. SWOT Analysis

7.12. Microsoft Healthcare

7.12.1. Business Overview

7.12.2. Financial Performance

7.12.3. Product/Service Offerings

7.12.4. Strategies & recent developments

7.12.5. SWOT Analysis

7.13. GE Healthcare

7.13.1. Business Overview

7.13.2. Financial Performance

7.13.3. Product/Service Offerings

7.13.4. Strategies & recent developments

7.13.5. SWOT Analysis

7.14. Siemens Healthineers

7.14.1. Business Overview

7.14.2. Financial Performance

7.14.3. Product/Service Offerings

7.14.4. Strategies & recent developments

7.14.5. SWOT Analysis

7.15. Philips Healthcare

7.15.1. Business Overview

7.15.2. Financial Performance

7.15.3. Product/Service Offerings

7.15.4. Strategies & recent developments

7.15.5. SWOT Analysis